Review



one-phase exponential growth model in nonlinear regression (curve fit)  (GraphPad Software Inc)


Bioz Verified Symbol GraphPad Software Inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    GraphPad Software Inc one-phase exponential growth model in nonlinear regression (curve fit)
    One Phase Exponential Growth Model In Nonlinear Regression (Curve Fit), supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/one-phase exponential growth model in nonlinear regression (curve fit)/product/GraphPad Software Inc
    Average 90 stars, based on 1 article reviews
    one-phase exponential growth model in nonlinear regression (curve fit) - by Bioz Stars, 2026-06
    90/100 stars

    Images



    Similar Products

    90
    GraphPad Software Inc one-phase exponential growth model in nonlinear regression (curve fit)
    One Phase Exponential Growth Model In Nonlinear Regression (Curve Fit), supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/one-phase exponential growth model in nonlinear regression (curve fit)/product/GraphPad Software Inc
    Average 90 stars, based on 1 article reviews
    one-phase exponential growth model in nonlinear regression (curve fit) - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    GraphPad Software Inc exponential growth curve
    Exponential Growth Curve, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/exponential growth curve/product/GraphPad Software Inc
    Average 90 stars, based on 1 article reviews
    exponential growth curve - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    GraphPad Software Inc exponential growth curve model in graphpad prism 10.1.2
    Exponential Growth Curve Model In Graphpad Prism 10.1.2, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/exponential growth curve model in graphpad prism 10.1.2/product/GraphPad Software Inc
    Average 90 stars, based on 1 article reviews
    exponential growth curve model in graphpad prism 10.1.2 - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    GraphPad Software Inc exponential growth curve model
    (A) Four stable cell lines were generated via lentiviral transduction that express similar levels of 2xMARS-nGFP and varying levels of GFP, which was under control of either a PGK or CMV promoter (the three CMV-GFP-expressing lines were isolated by FACS, sorting for different levels of GFP expression). Shown are representative Western blots showing GFP (asterisk denotes a longer CMV-GFP product potentially arising from an upstream alternative start codon) and 2xMARS-nGFP (mCherry blot) expression levels in these cell lines alongside blots of purified GFP and mCherry protein standards. (B) Quantification of GFP to 2xMARS-nGFP molar ratios in HeLa cells stably expressing 2xMARS-nGFP and various levels of GFP from (A). (C-D) Imaging analysis of GFP recruitment to the PM during mitosis at different stoichiometries of GFP to 2xMARS-nGFP determined by quantitative image analysis. (C) Quantification of the PM to cytosolic fluorescence ratios of GFP as a readout for measuring GFP recruitment levels by 2xMARS-nGFP. For PGK-GFP: n=8 cells for low GFP expression, n=4 cells for medium expression, and n=7 cells for high expression. For CMV-GFP cell lines, n=10 cells each for low, medium, and high GFP expression level. Cells analyzed came from two independent experiments (one-way ANOVA with Tukey post hoc multiple comparisons test). Note: CMV-GFP cells were sorted by FACS to generate three separate cell lines with low, medium, and high GFP expression, and images were acquired for each cell line. For PGK-GFP cells, the low, medium, and high cells were all from a single cell line and are categorized based on GFP fluorescence intensity during imaging analysis by ImageJ post-acquisition. (D) Representative micrographs for HeLa cells stably expressing 2xMARS-nGFP and varying levels of GFP analyzed in (C). Brightness of the GFP channel was adjusted post-acquisition for better visualization of the weaker fluorescence signals for PGK-GFP and CMV-GFP low cells. (E) Quantification of mean fluorescence intensity in the cytosol during interphase as a means to determine GFP expression levels in PGK-GFP low, medium, high cells and CMV-GFP low cells (n = 40 cells from two independent experiments). Compared to CMV-GFP low cells, PGK-GFP low cells exhibited an average of 7.6x lower expression, PGK-GFP medium cells exhibited ∼2.2x lower expression, and PGK-GFP-high cells exhibited ∼1.1x higher expression. Converting to GFP : 2xMARS-nGFP molar ratio in these cells, the estimated ratios are 1.8 (low), 6.2 (medium), and 15.1 (high). (F-G) Ectopic expression of MARS and 2xMARS-nGFP did not negatively impact rates of cell division and proliferation. (F) Representative growth curves for wild-type (WT) HeLa cells and those stably expressing MARS and 2xMARS-nGFP (n=2 technical replicates for each curve). Raw data (faded-color curves with error bar) acquired by IncuCyte Live-Cell Analysis System were fitted using GraphPad Prism <t>(Exponential</t> growth curve model). Fitted curves are shown as solid lines. (G) Doubling time of the three cell lines calculated from the fitted growth curves (n = 3 biological replicates, one-way ANOVA with Tukey post hoc multiple comparisons test).
    Exponential Growth Curve Model, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/exponential growth curve model/product/GraphPad Software Inc
    Average 90 stars, based on 1 article reviews
    exponential growth curve model - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    GraphPad Software Inc non-linear curve fit and exponential growth calculation graphpad prism
    (A) Four stable cell lines were generated via lentiviral transduction that express similar levels of 2xMARS-nGFP and varying levels of GFP, which was under control of either a PGK or CMV promoter (the three CMV-GFP-expressing lines were isolated by FACS, sorting for different levels of GFP expression). Shown are representative Western blots showing GFP (asterisk denotes a longer CMV-GFP product potentially arising from an upstream alternative start codon) and 2xMARS-nGFP (mCherry blot) expression levels in these cell lines alongside blots of purified GFP and mCherry protein standards. (B) Quantification of GFP to 2xMARS-nGFP molar ratios in HeLa cells stably expressing 2xMARS-nGFP and various levels of GFP from (A). (C-D) Imaging analysis of GFP recruitment to the PM during mitosis at different stoichiometries of GFP to 2xMARS-nGFP determined by quantitative image analysis. (C) Quantification of the PM to cytosolic fluorescence ratios of GFP as a readout for measuring GFP recruitment levels by 2xMARS-nGFP. For PGK-GFP: n=8 cells for low GFP expression, n=4 cells for medium expression, and n=7 cells for high expression. For CMV-GFP cell lines, n=10 cells each for low, medium, and high GFP expression level. Cells analyzed came from two independent experiments (one-way ANOVA with Tukey post hoc multiple comparisons test). Note: CMV-GFP cells were sorted by FACS to generate three separate cell lines with low, medium, and high GFP expression, and images were acquired for each cell line. For PGK-GFP cells, the low, medium, and high cells were all from a single cell line and are categorized based on GFP fluorescence intensity during imaging analysis by ImageJ post-acquisition. (D) Representative micrographs for HeLa cells stably expressing 2xMARS-nGFP and varying levels of GFP analyzed in (C). Brightness of the GFP channel was adjusted post-acquisition for better visualization of the weaker fluorescence signals for PGK-GFP and CMV-GFP low cells. (E) Quantification of mean fluorescence intensity in the cytosol during interphase as a means to determine GFP expression levels in PGK-GFP low, medium, high cells and CMV-GFP low cells (n = 40 cells from two independent experiments). Compared to CMV-GFP low cells, PGK-GFP low cells exhibited an average of 7.6x lower expression, PGK-GFP medium cells exhibited ∼2.2x lower expression, and PGK-GFP-high cells exhibited ∼1.1x higher expression. Converting to GFP : 2xMARS-nGFP molar ratio in these cells, the estimated ratios are 1.8 (low), 6.2 (medium), and 15.1 (high). (F-G) Ectopic expression of MARS and 2xMARS-nGFP did not negatively impact rates of cell division and proliferation. (F) Representative growth curves for wild-type (WT) HeLa cells and those stably expressing MARS and 2xMARS-nGFP (n=2 technical replicates for each curve). Raw data (faded-color curves with error bar) acquired by IncuCyte Live-Cell Analysis System were fitted using GraphPad Prism <t>(Exponential</t> growth curve model). Fitted curves are shown as solid lines. (G) Doubling time of the three cell lines calculated from the fitted growth curves (n = 3 biological replicates, one-way ANOVA with Tukey post hoc multiple comparisons test).
    Non Linear Curve Fit And Exponential Growth Calculation Graphpad Prism, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/non-linear curve fit and exponential growth calculation graphpad prism/product/GraphPad Software Inc
    Average 90 stars, based on 1 article reviews
    non-linear curve fit and exponential growth calculation graphpad prism - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    GraphPad Software Inc exponential growth curves
    (A) Four stable cell lines were generated via lentiviral transduction that express similar levels of 2xMARS-nGFP and varying levels of GFP, which was under control of either a PGK or CMV promoter (the three CMV-GFP-expressing lines were isolated by FACS, sorting for different levels of GFP expression). Shown are representative Western blots showing GFP (asterisk denotes a longer CMV-GFP product potentially arising from an upstream alternative start codon) and 2xMARS-nGFP (mCherry blot) expression levels in these cell lines alongside blots of purified GFP and mCherry protein standards. (B) Quantification of GFP to 2xMARS-nGFP molar ratios in HeLa cells stably expressing 2xMARS-nGFP and various levels of GFP from (A). (C-D) Imaging analysis of GFP recruitment to the PM during mitosis at different stoichiometries of GFP to 2xMARS-nGFP determined by quantitative image analysis. (C) Quantification of the PM to cytosolic fluorescence ratios of GFP as a readout for measuring GFP recruitment levels by 2xMARS-nGFP. For PGK-GFP: n=8 cells for low GFP expression, n=4 cells for medium expression, and n=7 cells for high expression. For CMV-GFP cell lines, n=10 cells each for low, medium, and high GFP expression level. Cells analyzed came from two independent experiments (one-way ANOVA with Tukey post hoc multiple comparisons test). Note: CMV-GFP cells were sorted by FACS to generate three separate cell lines with low, medium, and high GFP expression, and images were acquired for each cell line. For PGK-GFP cells, the low, medium, and high cells were all from a single cell line and are categorized based on GFP fluorescence intensity during imaging analysis by ImageJ post-acquisition. (D) Representative micrographs for HeLa cells stably expressing 2xMARS-nGFP and varying levels of GFP analyzed in (C). Brightness of the GFP channel was adjusted post-acquisition for better visualization of the weaker fluorescence signals for PGK-GFP and CMV-GFP low cells. (E) Quantification of mean fluorescence intensity in the cytosol during interphase as a means to determine GFP expression levels in PGK-GFP low, medium, high cells and CMV-GFP low cells (n = 40 cells from two independent experiments). Compared to CMV-GFP low cells, PGK-GFP low cells exhibited an average of 7.6x lower expression, PGK-GFP medium cells exhibited ∼2.2x lower expression, and PGK-GFP-high cells exhibited ∼1.1x higher expression. Converting to GFP : 2xMARS-nGFP molar ratio in these cells, the estimated ratios are 1.8 (low), 6.2 (medium), and 15.1 (high). (F-G) Ectopic expression of MARS and 2xMARS-nGFP did not negatively impact rates of cell division and proliferation. (F) Representative growth curves for wild-type (WT) HeLa cells and those stably expressing MARS and 2xMARS-nGFP (n=2 technical replicates for each curve). Raw data (faded-color curves with error bar) acquired by IncuCyte Live-Cell Analysis System were fitted using GraphPad Prism <t>(Exponential</t> growth curve model). Fitted curves are shown as solid lines. (G) Doubling time of the three cell lines calculated from the fitted growth curves (n = 3 biological replicates, one-way ANOVA with Tukey post hoc multiple comparisons test).
    Exponential Growth Curves, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/exponential growth curves/product/GraphPad Software Inc
    Average 90 stars, based on 1 article reviews
    exponential growth curves - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    GraphPad Software Inc global curve-fitting by nonlinear regression (exponential malthusian growth)
    (A) Four stable cell lines were generated via lentiviral transduction that express similar levels of 2xMARS-nGFP and varying levels of GFP, which was under control of either a PGK or CMV promoter (the three CMV-GFP-expressing lines were isolated by FACS, sorting for different levels of GFP expression). Shown are representative Western blots showing GFP (asterisk denotes a longer CMV-GFP product potentially arising from an upstream alternative start codon) and 2xMARS-nGFP (mCherry blot) expression levels in these cell lines alongside blots of purified GFP and mCherry protein standards. (B) Quantification of GFP to 2xMARS-nGFP molar ratios in HeLa cells stably expressing 2xMARS-nGFP and various levels of GFP from (A). (C-D) Imaging analysis of GFP recruitment to the PM during mitosis at different stoichiometries of GFP to 2xMARS-nGFP determined by quantitative image analysis. (C) Quantification of the PM to cytosolic fluorescence ratios of GFP as a readout for measuring GFP recruitment levels by 2xMARS-nGFP. For PGK-GFP: n=8 cells for low GFP expression, n=4 cells for medium expression, and n=7 cells for high expression. For CMV-GFP cell lines, n=10 cells each for low, medium, and high GFP expression level. Cells analyzed came from two independent experiments (one-way ANOVA with Tukey post hoc multiple comparisons test). Note: CMV-GFP cells were sorted by FACS to generate three separate cell lines with low, medium, and high GFP expression, and images were acquired for each cell line. For PGK-GFP cells, the low, medium, and high cells were all from a single cell line and are categorized based on GFP fluorescence intensity during imaging analysis by ImageJ post-acquisition. (D) Representative micrographs for HeLa cells stably expressing 2xMARS-nGFP and varying levels of GFP analyzed in (C). Brightness of the GFP channel was adjusted post-acquisition for better visualization of the weaker fluorescence signals for PGK-GFP and CMV-GFP low cells. (E) Quantification of mean fluorescence intensity in the cytosol during interphase as a means to determine GFP expression levels in PGK-GFP low, medium, high cells and CMV-GFP low cells (n = 40 cells from two independent experiments). Compared to CMV-GFP low cells, PGK-GFP low cells exhibited an average of 7.6x lower expression, PGK-GFP medium cells exhibited ∼2.2x lower expression, and PGK-GFP-high cells exhibited ∼1.1x higher expression. Converting to GFP : 2xMARS-nGFP molar ratio in these cells, the estimated ratios are 1.8 (low), 6.2 (medium), and 15.1 (high). (F-G) Ectopic expression of MARS and 2xMARS-nGFP did not negatively impact rates of cell division and proliferation. (F) Representative growth curves for wild-type (WT) HeLa cells and those stably expressing MARS and 2xMARS-nGFP (n=2 technical replicates for each curve). Raw data (faded-color curves with error bar) acquired by IncuCyte Live-Cell Analysis System were fitted using GraphPad Prism <t>(Exponential</t> growth curve model). Fitted curves are shown as solid lines. (G) Doubling time of the three cell lines calculated from the fitted growth curves (n = 3 biological replicates, one-way ANOVA with Tukey post hoc multiple comparisons test).
    Global Curve Fitting By Nonlinear Regression (Exponential Malthusian Growth), supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/global curve-fitting by nonlinear regression (exponential malthusian growth)/product/GraphPad Software Inc
    Average 90 stars, based on 1 article reviews
    global curve-fitting by nonlinear regression (exponential malthusian growth) - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    GraphPad Software Inc exponential growth curve modeling
    A Experimental setup of the syngeneic mouse colon cancer model, indicating the irradiation of cells prior to injection. B Growth curves of wildtype (WT) and ADAM12-knockout (A12 −/− ) tumors following irradiation of cancer cells with 0 Gy or 5 Gy prior injection. C Time required for the different groups to reach the tumor size endpoint. D , E Kaplan–Meier curves showing the survival of mice bearing WT or A12 −/− tumors without irradiation of cancer cells prior to injection ( D ) or following 5 Gy irradiation of cancer cells prior to injection ( E ). Extra sum-of-squares F -test of <t>exponential</t> growth models ( B ), Welch’s one-way ANOVA with correction for multiple comparisons using FDR control by Benjamini, Krieger, and Yekutieli method ( C ) or Log-rank test ( D , E ) were applied to test for significant differences: * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001.
    Exponential Growth Curve Modeling, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/exponential growth curve modeling/product/GraphPad Software Inc
    Average 90 stars, based on 1 article reviews
    exponential growth curve modeling - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    GraphPad Software Inc growth curve - exponential plateau toolbox
    A Experimental setup of the syngeneic mouse colon cancer model, indicating the irradiation of cells prior to injection. B Growth curves of wildtype (WT) and ADAM12-knockout (A12 −/− ) tumors following irradiation of cancer cells with 0 Gy or 5 Gy prior injection. C Time required for the different groups to reach the tumor size endpoint. D , E Kaplan–Meier curves showing the survival of mice bearing WT or A12 −/− tumors without irradiation of cancer cells prior to injection ( D ) or following 5 Gy irradiation of cancer cells prior to injection ( E ). Extra sum-of-squares F -test of <t>exponential</t> growth models ( B ), Welch’s one-way ANOVA with correction for multiple comparisons using FDR control by Benjamini, Krieger, and Yekutieli method ( C ) or Log-rank test ( D , E ) were applied to test for significant differences: * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001.
    Growth Curve Exponential Plateau Toolbox, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/growth curve - exponential plateau toolbox/product/GraphPad Software Inc
    Average 90 stars, based on 1 article reviews
    growth curve - exponential plateau toolbox - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    Image Search Results


    (A) Four stable cell lines were generated via lentiviral transduction that express similar levels of 2xMARS-nGFP and varying levels of GFP, which was under control of either a PGK or CMV promoter (the three CMV-GFP-expressing lines were isolated by FACS, sorting for different levels of GFP expression). Shown are representative Western blots showing GFP (asterisk denotes a longer CMV-GFP product potentially arising from an upstream alternative start codon) and 2xMARS-nGFP (mCherry blot) expression levels in these cell lines alongside blots of purified GFP and mCherry protein standards. (B) Quantification of GFP to 2xMARS-nGFP molar ratios in HeLa cells stably expressing 2xMARS-nGFP and various levels of GFP from (A). (C-D) Imaging analysis of GFP recruitment to the PM during mitosis at different stoichiometries of GFP to 2xMARS-nGFP determined by quantitative image analysis. (C) Quantification of the PM to cytosolic fluorescence ratios of GFP as a readout for measuring GFP recruitment levels by 2xMARS-nGFP. For PGK-GFP: n=8 cells for low GFP expression, n=4 cells for medium expression, and n=7 cells for high expression. For CMV-GFP cell lines, n=10 cells each for low, medium, and high GFP expression level. Cells analyzed came from two independent experiments (one-way ANOVA with Tukey post hoc multiple comparisons test). Note: CMV-GFP cells were sorted by FACS to generate three separate cell lines with low, medium, and high GFP expression, and images were acquired for each cell line. For PGK-GFP cells, the low, medium, and high cells were all from a single cell line and are categorized based on GFP fluorescence intensity during imaging analysis by ImageJ post-acquisition. (D) Representative micrographs for HeLa cells stably expressing 2xMARS-nGFP and varying levels of GFP analyzed in (C). Brightness of the GFP channel was adjusted post-acquisition for better visualization of the weaker fluorescence signals for PGK-GFP and CMV-GFP low cells. (E) Quantification of mean fluorescence intensity in the cytosol during interphase as a means to determine GFP expression levels in PGK-GFP low, medium, high cells and CMV-GFP low cells (n = 40 cells from two independent experiments). Compared to CMV-GFP low cells, PGK-GFP low cells exhibited an average of 7.6x lower expression, PGK-GFP medium cells exhibited ∼2.2x lower expression, and PGK-GFP-high cells exhibited ∼1.1x higher expression. Converting to GFP : 2xMARS-nGFP molar ratio in these cells, the estimated ratios are 1.8 (low), 6.2 (medium), and 15.1 (high). (F-G) Ectopic expression of MARS and 2xMARS-nGFP did not negatively impact rates of cell division and proliferation. (F) Representative growth curves for wild-type (WT) HeLa cells and those stably expressing MARS and 2xMARS-nGFP (n=2 technical replicates for each curve). Raw data (faded-color curves with error bar) acquired by IncuCyte Live-Cell Analysis System were fitted using GraphPad Prism (Exponential growth curve model). Fitted curves are shown as solid lines. (G) Doubling time of the three cell lines calculated from the fitted growth curves (n = 3 biological replicates, one-way ANOVA with Tukey post hoc multiple comparisons test).

    Journal: bioRxiv

    Article Title: A phosphorylation-controlled switch confers cell cycle-dependent protein relocalization

    doi: 10.1101/2024.06.05.597552

    Figure Lengend Snippet: (A) Four stable cell lines were generated via lentiviral transduction that express similar levels of 2xMARS-nGFP and varying levels of GFP, which was under control of either a PGK or CMV promoter (the three CMV-GFP-expressing lines were isolated by FACS, sorting for different levels of GFP expression). Shown are representative Western blots showing GFP (asterisk denotes a longer CMV-GFP product potentially arising from an upstream alternative start codon) and 2xMARS-nGFP (mCherry blot) expression levels in these cell lines alongside blots of purified GFP and mCherry protein standards. (B) Quantification of GFP to 2xMARS-nGFP molar ratios in HeLa cells stably expressing 2xMARS-nGFP and various levels of GFP from (A). (C-D) Imaging analysis of GFP recruitment to the PM during mitosis at different stoichiometries of GFP to 2xMARS-nGFP determined by quantitative image analysis. (C) Quantification of the PM to cytosolic fluorescence ratios of GFP as a readout for measuring GFP recruitment levels by 2xMARS-nGFP. For PGK-GFP: n=8 cells for low GFP expression, n=4 cells for medium expression, and n=7 cells for high expression. For CMV-GFP cell lines, n=10 cells each for low, medium, and high GFP expression level. Cells analyzed came from two independent experiments (one-way ANOVA with Tukey post hoc multiple comparisons test). Note: CMV-GFP cells were sorted by FACS to generate three separate cell lines with low, medium, and high GFP expression, and images were acquired for each cell line. For PGK-GFP cells, the low, medium, and high cells were all from a single cell line and are categorized based on GFP fluorescence intensity during imaging analysis by ImageJ post-acquisition. (D) Representative micrographs for HeLa cells stably expressing 2xMARS-nGFP and varying levels of GFP analyzed in (C). Brightness of the GFP channel was adjusted post-acquisition for better visualization of the weaker fluorescence signals for PGK-GFP and CMV-GFP low cells. (E) Quantification of mean fluorescence intensity in the cytosol during interphase as a means to determine GFP expression levels in PGK-GFP low, medium, high cells and CMV-GFP low cells (n = 40 cells from two independent experiments). Compared to CMV-GFP low cells, PGK-GFP low cells exhibited an average of 7.6x lower expression, PGK-GFP medium cells exhibited ∼2.2x lower expression, and PGK-GFP-high cells exhibited ∼1.1x higher expression. Converting to GFP : 2xMARS-nGFP molar ratio in these cells, the estimated ratios are 1.8 (low), 6.2 (medium), and 15.1 (high). (F-G) Ectopic expression of MARS and 2xMARS-nGFP did not negatively impact rates of cell division and proliferation. (F) Representative growth curves for wild-type (WT) HeLa cells and those stably expressing MARS and 2xMARS-nGFP (n=2 technical replicates for each curve). Raw data (faded-color curves with error bar) acquired by IncuCyte Live-Cell Analysis System were fitted using GraphPad Prism (Exponential growth curve model). Fitted curves are shown as solid lines. (G) Doubling time of the three cell lines calculated from the fitted growth curves (n = 3 biological replicates, one-way ANOVA with Tukey post hoc multiple comparisons test).

    Article Snippet: Confluency data within the exponential growth phase were plotted and fitted for doubling time calculation using the Exponential growth curve model in GraphPad Prism.

    Techniques: Stable Transfection, Generated, Transduction, Control, Expressing, Isolation, Western Blot, Purification, Imaging, Fluorescence, Cell Analysis

    A Experimental setup of the syngeneic mouse colon cancer model, indicating the irradiation of cells prior to injection. B Growth curves of wildtype (WT) and ADAM12-knockout (A12 −/− ) tumors following irradiation of cancer cells with 0 Gy or 5 Gy prior injection. C Time required for the different groups to reach the tumor size endpoint. D , E Kaplan–Meier curves showing the survival of mice bearing WT or A12 −/− tumors without irradiation of cancer cells prior to injection ( D ) or following 5 Gy irradiation of cancer cells prior to injection ( E ). Extra sum-of-squares F -test of exponential growth models ( B ), Welch’s one-way ANOVA with correction for multiple comparisons using FDR control by Benjamini, Krieger, and Yekutieli method ( C ) or Log-rank test ( D , E ) were applied to test for significant differences: * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001.

    Journal: Cancer Gene Therapy

    Article Title: ADAM12 expression is upregulated in cancer cells upon radiation and constitutes a prognostic factor in rectal cancer patients following radiotherapy

    doi: 10.1038/s41417-023-00643-w

    Figure Lengend Snippet: A Experimental setup of the syngeneic mouse colon cancer model, indicating the irradiation of cells prior to injection. B Growth curves of wildtype (WT) and ADAM12-knockout (A12 −/− ) tumors following irradiation of cancer cells with 0 Gy or 5 Gy prior injection. C Time required for the different groups to reach the tumor size endpoint. D , E Kaplan–Meier curves showing the survival of mice bearing WT or A12 −/− tumors without irradiation of cancer cells prior to injection ( D ) or following 5 Gy irradiation of cancer cells prior to injection ( E ). Extra sum-of-squares F -test of exponential growth models ( B ), Welch’s one-way ANOVA with correction for multiple comparisons using FDR control by Benjamini, Krieger, and Yekutieli method ( C ) or Log-rank test ( D , E ) were applied to test for significant differences: * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001.

    Article Snippet: Comparison of tumor growth was performed by modeling exponential growth curves for each group and comparing models using extra sum-of-squares F -test in GraphPad (v.9.3.1).

    Techniques: Irradiation, Injection, Knock-Out, Control